Jonathan S. Serody

21.4k total citations · 3 hit papers
184 papers, 9.0k citations indexed

About

Jonathan S. Serody is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Jonathan S. Serody has authored 184 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Immunology, 85 papers in Oncology and 69 papers in Hematology. Recurrent topics in Jonathan S. Serody's work include Hematopoietic Stem Cell Transplantation (59 papers), Immunotherapy and Immune Responses (54 papers) and Immune Cell Function and Interaction (47 papers). Jonathan S. Serody is often cited by papers focused on Hematopoietic Stem Cell Transplantation (59 papers), Immunotherapy and Immune Responses (54 papers) and Immune Cell Function and Interaction (47 papers). Jonathan S. Serody collaborates with scholars based in United States, Germany and China. Jonathan S. Serody's co-authors include Bruce R. Blazar, Benjamin G. Vincent, Angela Panoskaltsis‐Mortari, Charles M. Perou, Karen P. McKinnon, Joel S. Parker, Christian Wysocki, James M. Coghill, Christof C. Smith and Shengjie Chai and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jonathan S. Serody

179 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

2017 590 citations Karen P. McKinnon, Shengjie Chai et al. profile →
B Cell Function in the Tumor Microenvironment

2022 193 citations Benjamin G. Vincent, Jonathan S. Serody et al. profile →
Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment

2024 62 citations Jonathan S. Serody et al. profile →

Peers

Countries citing papers authored by Jonathan S. Serody

Since Specialization

Citations

This map shows the geographic impact of Jonathan S. Serody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Serody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Serody more than expected).

Fields of papers citing papers by Jonathan S. Serody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Serody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Serody. The network helps show where Jonathan S. Serody may publish in the future.

Co-authorship network of co-authors of Jonathan S. Serody

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Serody. A scholar is included among the top collaborators of Jonathan S. Serody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Serody. Jonathan S. Serody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD	Blood Advances	Danny Bruce, Sonia J. Laurie et al.	1
2	Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults	Open Forum Infectious Diseases	Jonathan S. Serody, Paul M. Armistead et al.	0
3	Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation	Nature Communications	Sonia J. Laurie, Danny Bruce et al.	4
4	Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy	Biomaterials	Mostafa Yazdimamaghani, Chaemin Lim et al.	13
5	CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/ Refractory Hodgkin Lymphoma and CD30+ Cutaneous T Cell Lymphoma	Transplantation and Cellular Therapy	Natalie S. Grover, Anastasia Ivanova et al.	2
6	Infusion of CD30 CAR T Cells Is Safe and Effective As Consolidation Following Autologous Hematopoietic Stem Cell Transplant	Transplantation and Cellular Therapy	Marcie Riches, Thomas C. Shea et al.	3
7	Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes	Cancer Immunology Research	Christof C. Smith, Shengjie Chai et al.	47
8	Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality	The Journal of Immunology	Govindarajan Thangavelu, Yu‐Chi Lee et al.	11
9	Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation	Biology of Blood and Marrow Transplantation	Jessica Davis, Anastasia Ivanova et al.	8
10	Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML)	Blood	Joshua F. Zeidner, Benjamin G. Vincent et al.	10
11	Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease	Journal of Clinical Investigation	Danny Bruce, Heather E. Stefanski et al.	85
12	A Novel Process for the Expansion of Functional Human ILC2 Cells for GCHD Prevention	Blood	Yan Xing, Heather E. Stefanski et al.	5
13	A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases	Clinical Cancer Research	Anne Montfort, Oliver M.T. Pearce et al.	172
14	GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells	Blood	Brent H. Koehn, Petya Apostolova et al.	91
15	Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer	Clinical Cancer Research	Michael D. Iglesia, Benjamin G. Vincent et al.	194
16	C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1	Molecular Cancer Research	Qing Wu, Michelle L. West et al.	8
17	The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells	Cancer Research	Hendrik W. van Deventer, Joseph E. Burgents et al.	135
18	The Immunosuppressive Tumor Environment Is the Major Impediment to Successful Therapeutic Vaccination in Neu Transgenic Mice	Journal of Immunotherapy	Joseph E. Burgents, Timothy P. Moran et al.	12
19	C-C Chemokine Receptor 5 on Pulmonary Fibrocytes Facilitates Migration and Promotes Metastasis via Matrix Metalloproteinase 9	American Journal Of Pathology	Hendrik W. van Deventer, Qing Wu et al.	48
20	Host Absence of CCR5 Potentiates Dendritic Cell Vaccination	The Journal of Immunology	Jennifer J. Kuhns, Susan E. Burkett et al.	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact